Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.
Primary Purpose
Glaucoma, Blindness, Acquired, End-Stage Glaucoma
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Laminar drainage implant surgery.
Sponsored by
About this trial
This is an interventional device feasibility trial for Glaucoma focused on measuring glaucoma, glaucoma surgery, glaucoma drainage device, glaucoma implant, blindness
Eligibility Criteria
Inclusion Criteria:
- patients aged 18 years or older with a painful blind eye refractory to clinical treatment and an intraocular pressure (IOP) ≥ 30 mmHg.
Exclusion Criteria:
- eyes with extensive conjunctival scarring, a disorganized anterior segment, or retinal detachment identified by ophthalmoscopy or B-scan ultrasonography.
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
laminar drainage implant surgery
Arm Description
patients included and operated
Outcomes
Primary Outcome Measures
Change for baseline of intra-ocular pressure (Goldmann applanation tonometry)
The criteria for IOP reduction success were 15 mmHg and a 20% reduction compared to the baseline preoperative IOP.
Secondary Outcome Measures
Ocular pain intensity ratting change from baseline
Ocular pain intensity was assessed before and after surgery using a verbal Numerical scale.
Conjunctival discharge presence/absence change from baseline
conjunctival discharge was assessed by slit-lamp examination
Conjunctival erosion or retraction appearence after surgery
Presence or abscence of conjunctival tissue erosion or retraction, caused by the tested
Corneal edema presence change from baseline
assessed by slit-lamp biomicroscopy was classified as "present" or "abscent"
Anterior chamber depth (gonioscopy) change from baseline
A shallow AC was considered a Spaeth classification grade of I or II and a flat AC was considered grade III. A filtering bleb height above the LDI profile was considered elevated; otherwise, it was classified as flat
Optic coherence tomography (OCT) assessment qualitative study after surgery
OCT image were obtained in 8 patients after surgery in order to imaging study the implant and its relation with the eye structures.
Filtering bleg height variation from baseline
bleb heigh(if not above implant profile)t was slit-lamp assessed. classified as "elevated" (above implant profile) or "flat"
Conjunctival hyperemia change comparing to baseline
conjunctival inflamation graduation assessed by slit-lamp examination ("present or abscent")
Full Information
NCT ID
NCT03166566
First Posted
May 22, 2017
Last Updated
May 23, 2017
Sponsor
Federal University of Minas Gerais
1. Study Identification
Unique Protocol Identification Number
NCT03166566
Brief Title
Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.
Official Title
Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.
Study Type
Interventional
2. Study Status
Record Verification Date
May 2017
Overall Recruitment Status
Completed
Study Start Date
March 1, 2011 (Actual)
Primary Completion Date
December 2, 2015 (Actual)
Study Completion Date
September 2, 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of Minas Gerais
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Purpose: To assess the feasibility of a surgical technique and present the preliminary safety results of a new glaucoma device devoid of a tube in painful blind eyes.
Methods: Fifteen end-stage glaucomatous eyes without light perception vision were treated with a novel laminar drainage implant. Intraocular pressure was measured preoperatively and up to 24 months after surgery using a Goldmann applanation tonometer. A scale ranging from 0 to 10 was used to evaluate ocular pain. Conjunctival hyperemia, discharge, erosion or retraction, aqueous humor leakage, corneal edema, hyphema, anterior chamber cells and depth, dislocation of the implant, and filtering bleb height were assessed by slit-lamp biomicroscopy. Anterior segment optical coherence tomography was also assessed.
Detailed Description
Methods: Light perception was tested in the preoperative assessment. The following parameters were evaluated at the pre- and postoperative visits: morning Goldmann applanation tonometry; anterior segment biomicroscopy, gonioscopy, and eye pain intensity. Postoperative visits occurred on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years. The criteria for IOP reduction success were 15 mmHg and a 20% reduction compared to the baseline preoperative IOP. Biomicroscopy variables included the presence or absence of hyperemia, discharge, conjunctival erosion and retraction, aqueous humor leakage (Seidel test), corneal edema, hyphema, AC reaction and depth, and device dislocation. A shallow AC was considered a Spaeth classification grade of I or II and a flat AC was considered grade III. A filtering bleb height above the LDI profile was considered elevated; otherwise, it was classified as flat. Gonioscopy was performed preoperatively and postoperatively. Ocular pain intensity was assessed before and after surgery using a verbal Numerical Rating Scale ranging from zero to 10, with zero representing the absence of pain and 10 representing the worst eye pain ever felt before surgery.
Anterior segment optical coherence tomography (AS-OCT) (Visante®, Carl Zeiss Meditec®, Inc., Dublin, CA, USA) was performed postoperatively at the highest resolution (enhanced high-resolution corneal mode).
Reoperations to unblock the internal ostium were not considered failures; thereafter, the day of the second surgery was considered postoperative day 0.
LDI A human LDI was designed by one of the authors (S.J.) after a preclinical trial in rabbits with a similar device. It is a 150-µm-thick foil made of polymethylmethacrylate (PMMA), composed of three functional areas (Fig. 1): 1) the tip, which has a triangular shape and is inserted into the AC angle; 2) the intermediate portion, which has a rectangular shape (4.5 mm long × 4.0 mm wide) and is positioned inside a scleral tunnel; and 3) the posterior plate, which has a round shape (diameter = 12.5 mm) and is positioned between the sclera and conjunctiva. The LDI plate is positioned only 4.5 mm from the corneoscleral limbus and no allograft coverage is necessary. Its hypothetical mechanism of action is similar to those of popular GDIs and shunts the aqueous humor from the AC to the subconjunctival plate. The difference between their designs is the absence of a tube in the LDI. Thus, aqueous humor drainage is supposed to occur in the space between the inner walls of the scleral tunnel and LDI and/or thought is cleft.
LDI Surgery All surgeries were performed under local peribulbar anesthesia by the same surgeon (S.J.).
Statistical Analysis The sample size was calculated based on IOP standard deviation values from the first seven patients who were operated on (an internal pilot study) while considering 15 mmHg as the minimal clinically relevant difference to be detected.
Histogram inspection and Shapiro-Wilk tests were used to assess the assumption of the normality of variables. Wilcoxon's rank-sum test was used to compare the median pain intensity at each postoperative visit to that at the preoperative visit. Conjunctival hyperemia, AC cells, corneal edema, and hyphema variables were analyzed using McNemar's test. The comparison between the pre- and postoperative mean IOP was performed using Student's two-tailed paired t-test. Results were analyzed using SPSS® (Statistical Package for the Social Sciences) for Windows version 18.0 (IBM, Chicago, IL, USA) and the alpha level (type I error) was set at 0.05.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Glaucoma, Blindness, Acquired, End-Stage Glaucoma, Glaucoma Traumatic
Keywords
glaucoma, glaucoma surgery, glaucoma drainage device, glaucoma implant, blindness
7. Study Design
Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Actual)
8. Arms, Groups, and Interventions
Arm Title
laminar drainage implant surgery
Arm Type
Other
Arm Description
patients included and operated
Intervention Type
Device
Intervention Name(s)
Laminar drainage implant surgery.
Intervention Description
A clear corneal traction suture was placed to achieve superior-temporal quadrant exposure, where a 90° conjunctival fornix-based flap was made, associated with two radial relaxing incisions. A half-thickness scleral tunnel (4.5 mm from the limbus and 4.0 mm wide) was made using a crescent blade and a superior-temporal iridectomy was performed through . Then, the tunnel end was shunted to the AC using a 1.5-mm-wide blade with a sharp tip. The LDI was inserted into the scleral tunnel so that its tip was positioned in the AC periphery and the implant was anchored to the sclera using 7-0 polypropylene thread with two separate sutures. Next, fistula function was assessed by the aqueous humor leakage test at the scleral tunnel entry site. Then, the conjunctiva was repositioned and running sutures were performed with 7-0 polyglactin for the relaxing incisions and mattress sutures were performed in the limbus using 10-0 nylon.
Primary Outcome Measure Information:
Title
Change for baseline of intra-ocular pressure (Goldmann applanation tonometry)
Description
The criteria for IOP reduction success were 15 mmHg and a 20% reduction compared to the baseline preoperative IOP.
Time Frame
on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years.
Secondary Outcome Measure Information:
Title
Ocular pain intensity ratting change from baseline
Description
Ocular pain intensity was assessed before and after surgery using a verbal Numerical scale.
Time Frame
on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years.
Title
Conjunctival discharge presence/absence change from baseline
Description
conjunctival discharge was assessed by slit-lamp examination
Time Frame
on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years.
Title
Conjunctival erosion or retraction appearence after surgery
Description
Presence or abscence of conjunctival tissue erosion or retraction, caused by the tested
Time Frame
on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years.
Title
Corneal edema presence change from baseline
Description
assessed by slit-lamp biomicroscopy was classified as "present" or "abscent"
Time Frame
on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years.
Title
Anterior chamber depth (gonioscopy) change from baseline
Description
A shallow AC was considered a Spaeth classification grade of I or II and a flat AC was considered grade III. A filtering bleb height above the LDI profile was considered elevated; otherwise, it was classified as flat
Time Frame
on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years.
Title
Optic coherence tomography (OCT) assessment qualitative study after surgery
Description
OCT image were obtained in 8 patients after surgery in order to imaging study the implant and its relation with the eye structures.
Time Frame
from 6 months to two years after surgery.
Title
Filtering bleg height variation from baseline
Description
bleb heigh(if not above implant profile)t was slit-lamp assessed. classified as "elevated" (above implant profile) or "flat"
Time Frame
on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years.
Title
Conjunctival hyperemia change comparing to baseline
Description
conjunctival inflamation graduation assessed by slit-lamp examination ("present or abscent")
Time Frame
on days 1, 3, 7, 14, and 30, once a month up to 6 months, and every 6 months from 6 months to 2 years.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
patients aged 18 years or older with a painful blind eye refractory to clinical treatment and an intraocular pressure (IOP) ≥ 30 mmHg.
Exclusion Criteria:
eyes with extensive conjunctival scarring, a disorganized anterior segment, or retinal detachment identified by ophthalmoscopy or B-scan ultrasonography.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sebastião C. Sobrinho, Md, Ph.D
Organizational Affiliation
Hospital São Geraldo-Universidade Federal de Minas Gerais
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
25719229
Citation
Wolf A, Hod Y, Buckman G, Stein N, Geyer O. Use of Autologous Scleral Graft in Ahmed Glaucoma Valve Surgery. J Glaucoma. 2016 Apr;25(4):365-70. doi: 10.1097/IJG.0000000000000232.
Results Reference
background
PubMed Identifier
21621130
Citation
Hjermstad MJ, Fayers PM, Haugen DF, Caraceni A, Hanks GW, Loge JH, Fainsinger R, Aass N, Kaasa S; European Palliative Care Research Collaborative (EPCRC). Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage. 2011 Jun;41(6):1073-93. doi: 10.1016/j.jpainsymman.2010.08.016.
Results Reference
background
PubMed Identifier
28104418
Citation
Christakis PG, Zhang D, Budenz DL, Barton K, Tsai JC, Ahmed IIK; ABC-AVB Study Groups. Five-Year Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study. Am J Ophthalmol. 2017 Apr;176:118-126. doi: 10.1016/j.ajo.2017.01.003. Epub 2017 Jan 17.
Results Reference
result
PubMed Identifier
23873397
Citation
Thieme H, Choritz L, Schuart C, Wecke T. [Tube versus trabeculectomy study]. Ophthalmologe. 2013 Aug;110(8):728-32. doi: 10.1007/s00347-013-2840-z. German.
Results Reference
result
PubMed Identifier
28442686
Citation
Aref AA, Gedde SJ, Budenz DL. Glaucoma Drainage Implant Surgery. Dev Ophthalmol. 2017;59:43-52. doi: 10.1159/000458485. Epub 2017 Apr 25.
Results Reference
result
Learn more about this trial
Laminar Drainage Implant: Safety of a Novel Surgical Treatment for Refractory Glaucoma.
We'll reach out to this number within 24 hrs